Rigel Pharmaceuticals Inc.
RIGL | NASDAQ
$47.09
+$0.45 (+0.96%)
At close: Sep 21, 2026, 4:00 PM ET
$47.09
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 25.94M | 8.65M | 268.07M | 27.9M | 59.61M | 11.45M | 14.34M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M | -13.54M | 1.4M | -19.04M | -13.49M | -27.45M | -22.64M | -20.95M | -13.82M | 39.5M |
Depreciation & Amortization | 1.45M | 597K | 601K | 603K | 607K | 604K | 604K | 611K | 613K | 400K | 293K | 292K | 296K | 357K | 284K | 240K | 237K | 237K | 404K | 261K | 258K | 239K |
Stock-Based Compensation | 10.3M | 3.46M | 2.75M | 3.36M | 3.28M | 3.32M | 2.09M | 2.64M | 2.53M | 5.13M | 1.93M | 1.94M | 2.17M | 2.76M | 4.08M | 2.71M | 2.39M | 3.21M | 2.34M | 2.2M | 2.31M | 2.64M |
Other Working Capital | 10.5M | -10.92M | -1.98M | 1.91M | 10.66M | -18.17M | 7.39M | 6.74M | 5.08M | -4.96M | -3.5M | 1.91M | 2.26M | -1.72M | -5.83M | 1.61M | 1.93M | -3.32M | -795K | 3.64M | -56.42M | 67.62M |
Other Non-Cash Items | -11.29M | -170K | -246.1M | -467K | -40.23M | -190K | -332K | -92K | -159K | -205K | -370K | -127K | 5K | 279K | 148K | -203K | -174K | 710K | 941K | 962K | 1.38M | 145K |
Deferred Income Tax | 7.78M | 2.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -801K | -12.39M | -3.34M | -7.37M | 7.27M | -16.08M | -2.2M | 6.1M | -1.65M | -2.1M | -8.83M | 2.23M | 10.06M | 6.07M | -27.82M | 2.99M | -1.87M | -2.35M | -129K | 7.23M | 65.1M | -62.48M |
Operating Cash Flow | 33.38M | 2.73M | 21.98M | 24.03M | 30.54M | -893K | 14.5M | 21.68M | 302K | -5.01M | -6.24M | -1.36M | 5.93M | -4.07M | -21.91M | -13.3M | -12.91M | -25.64M | -19.09M | -10.3M | 55.22M | -19.96M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -26K | -10K | -222K | -138K | n/a | n/a | n/a | -15M | -73K | -189K | 36K | -224K | 21K | -170K | -407K | -71K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 264K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -28.9M | -23.92M | -38.92M | -53.89M | -39.03M | -21.65M | -17.71M | -2.21M | -7.55M | -7.8M | -12.98M | -9.44M | -8.78M | n/a | -2.85M | -19.05M | -264K | -7M | -24.38M | -45.63M | -67.15M | -4.3M |
Sales Maturities Of Investments | 108.73M | 15.95M | 13.55M | 20.73M | 15.75M | 11.1M | 6.75M | 6M | 18.7M | 8.25M | 6M | 8.25M | 11.75M | 15.65M | 21.17M | 29.42M | 20.8M | 29.85M | 30.85M | 1.4M | 17.9M | 11.9M |
Other Investing Acitivies | -70.35M | n/a | 12K | -12K | n/a | n/a | 72K | 26K | n/a | n/a | 110K | 22K | n/a | 127K | 350K | 279K | 264K | n/a | 21K | n/a | n/a | n/a |
Investing Cash Flow | 9.48M | -7.98M | -25.36M | -33.18M | -23.28M | -10.55M | -10.91M | 3.8M | 10.93M | 313K | -6.87M | -1.17M | 2.97M | 777K | 18.6M | 10.46M | 21.1M | 22.63M | 6.49M | -44.4M | -49.66M | 7.53M |
Debt Repayment | -15.25M | -7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.95M | n/a | 9.6M | -33K | 9.98M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -3.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -9.56M | n/a | -7.5M | n/a | n/a | 484K | 1.47M | -9.84M | -752K | -2.51M | 486K | -869K | -373K | -827K | -2.1M | -4.09M | -6.23M | -1.18M | 1.09M | 274K | 59.22M | 2.1M |
Financial Cash Flow | -22.62M | -10.92M | -4.57M | 4.27M | 418K | 484K | 1.47M | -9.84M | -752K | -2.51M | 486K | -869K | -373K | 19.12M | -2.1M | 5.51M | -5.66M | 8.8M | 1.09M | 274K | 59.22M | 2.1M |
Net Cash Flow | 20.24M | -16.17M | -7.95M | -4.87M | 7.68M | -10.96M | 5.05M | 15.64M | 10.48M | -7.21M | -12.63M | -3.4M | 8.53M | 15.83M | -5.41M | 2.67M | 2.52M | 5.79M | -11.51M | -54.42M | 64.78M | -10.33M |
Free Cash Flow | 33.38M | 2.73M | 21.99M | 24.02M | 30.54M | -893K | 14.48M | 21.67M | 80K | -5.15M | -6.24M | -1.36M | 5.93M | -19.07M | -21.98M | -13.49M | -12.88M | -25.86M | -19.07M | -10.47M | 54.81M | -20.03M |
Adj. Free Cash Flow | 23.08M | -731K | 19.24M | 20.66M | 27.26M | -4.22M | 12.39M | 19.03M | -2.45M | -10.29M | -8.17M | -3.3M | 3.76M | -21.83M | -26.06M | -16.2M | -15.27M | -29.07M | -21.4M | -12.67M | 52.5M | -22.67M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13.97M | n/a | -75.17K | 72K | -224K | 42K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -26K | -10K | -222K | -138K | n/a | n/a | n/a | -1.03M | -73K | -113.83K | -36K | n/a | -21K | -170K | -407K | -71K |
Owner Earnings | 33.38M | 2.73M | 21.98M | 24.03M | 30.54M | -893K | 14.5M | 21.68M | 302K | -5.01M | -6.24M | -1.36M | 5.93M | -18.05M | -21.91M | -13.38M | -12.84M | -25.86M | -19.04M | -10.3M | 55.22M | -19.96M |
Add to Watchlist
Select watchlists to add or remove RIGL